Back to ALNY Stock Lookup

ALNY Related Analyst Ratings

Jun 11, 2013 07:39 AM Morgan Stanley Starts Alnylam Pharmaceuticals (ALNY) at Overweight

May 24, 2013 07:17 AM Deutsche Bank Starts Alnylam Pharmaceuticals (ALNY) at Buy

Feb 8, 2013 07:18 AM JMP Securities Starts Alnylam Pharmaceuticals (ALNY) at Market Outperform

Feb 4, 2013 03:02 PM Needham & Company Boosts Alnylam (ALNY) PT to $28 on Medicines Co. Deal

Dec 12, 2012 06:41 AM Piper Jaffray Upgrades Alnylam Pharmaceuticals (ALNY) to Overweight

Aug 28, 2012 03:45 PM Leerink Swann Maintains Bullish Stance on Alnylam Pharmaceuticals (ANLY), Sees Dramatic Upside

Aug 7, 2012 09:02 AM Needham & Company Reiterates Buy on Alnylam Pharmaceuticals (ALNY), Says Stock Undervalued

Jul 17, 2012 07:49 AM Leerink Swann Starts Alnylam Pharmaceuticals (ALNY) at Outperform; Positive Phase 1 Results From ALN-TTR-02

Jul 16, 2012 02:28 PM Alnylam Pharmaceuticals (ALNY) Price Target Boosted at Needham & Company

May 30, 2012 01:09 PM Needham & Company Reiterates a 'Buy' on Alnylam Pharma (ALNY); Phase 2b Trial Misses, But Shares Still Undervalued

May 8, 2012 08:06 AM JPMorgan Starts Alnylam Pharmaceuticals (ALNY) at Overweight

May 4, 2012 09:11 AM Needham & Company Reiterates a 'Buy' on Alnylam Pharmaceuticals (ALNY); Focused on Development

Feb 10, 2012 09:35 AM Needham & Company Reiterates a 'Buy' on Alnylam Pharmaceuticals (ALNY); Accelerated ALN-TTR Development May Sustain Stock Momentum in 2012

Jan 4, 2012 11:57 AM Needham & Company Reiterates a 'Buy' on Alnylam (ALNY); Positive Results for ALN-PCS; Stock Remains a 2012 Favorite

Dec 23, 2011 07:35 AM Needham & Company 2012 Biotech Preview

Dec 15, 2011 10:51 AM JMP Securities Starts Alnylam Pharmaceuticals (ALNY) at Market Outperform

Nov 21, 2011 11:31 AM Needham & Company Reiterates a 'Buy' on Alnylam Pharmaceuticals (ALNY); Encouraging Clinical Data from ALN-TTR Program

Nov 2, 2011 08:19 AM Needham & Company Reiterates a 'Buy' on Alnylam Pharmaceuticals (ALNY); Initial Proof-of-Concept Data from Two Programs Expected by YE11

Oct 14, 2011 07:50 AM Rodman & Renshaw Starts Alnylam Pharmaceuticals (ALNY) at Market Outperform

Sep 22, 2011 01:59 PM Needham & Company Maintains a 'Buy' on Alnylam Pharmaceuticals (ALNY); Favorable View Based on Low Valuation

Aug 16, 2011 07:23 AM Piper Jaffray Upgrades Alnylam Pharmaceuticals (ALNY) to Overweight

May 6, 2011 09:38 AM McNicoll Lewis & Vlak Starts Alnylam Pharmaceuticals (ALNY) at Buy; Investing in the Next Leap of Human Therapeutics with RNA Interference (RNAi)

May 3, 2011 07:47 AM Needham & Company Reiterates a 'Buy' on Alnylam Pharmaceuticals (ALNY); Q1 Review

Feb 23, 2011 07:57 AM Needham & Company Upgrades Alnylam Pharmaceuticals (ALNY) to 'Buy' Based on Expected 2011 Clinical Pipeline News Flow and Low Valuation

Feb 18, 2011 07:56 AM Roth Capital Upgrades Alnylam Pharmaceuticals (ALNY) to Buy

May 20, 2010 08:05 AM ThinkEquity Initiates Coverage on Alnylam Pharmaceuticals (ALNY) with a Buy

Nov 24, 2009 08:37 AM Roth Capital Downgrades Alnylam Pharmaceuticals (ALNY) to Hold. Price Target Cut

Jul 14, 2009 07:30 AM Leerink Swann Upgrades Alnylam Pharmaceuticals (ALNY) to Market Perform; Good Progress Demonstrated

Jun 10, 2009 07:55 AM Roth Capital Initiates Coverage on Alnylam Pharmaceuticals (ALNY) with a Buy

Jun 10, 2009 07:53 AM Jefferies & Co Initiates Coverage on Alnylam Pharmaceuticals (ALNY) with a Buy

Feb 25, 2009 08:36 AM Needham & Co Upgrades Alnylam Pharmaceuticals (ALNY) to Hold Based on Valuation and Pipeline Progress

Sep 12, 2008 07:53 AM Thomas Weisel Initiates Coverage on Alnylam Pharm (ALNY) with a Marketweight

Sep 12, 2008 07:43 AM Thomas Weisel Starts Alnylam Pharmaceuticals (ALNY) at Market Weight

Aug 20, 2008 08:25 AM Leerink Swann Starts Alnylam Pharmaceuticals (ALNY) at Underperform

Mar 3, 2008 08:13 AM Needham & Co Downgrades Alnylam (ALNY) to Underperform

Dec 5, 2007 12:17 PM Cantor Fitzgerald Raises Price Target on Alnylam Pharmaceuticals (ALNY)

Oct 10, 2007 07:26 AM Piper Jaffray & Co. Downgrades Alnylam Pharmaceuticals (ALNY) to Market Perform

Sep 11, 2007 07:55 AM Cantor Fitzgerald upgrades Alnylam Pharmaceuticals (ALNY) to Buy

Aug 13, 2007 08:54 AM Needham Downgrades Alnylam Pharmaceuticals (ALNY) to Hold

Jul 9, 2007 01:51 PM Piper Jaffray raises their price target on Alnylam Pharmaceuticals (ALNY) to $30

Jul 9, 2007 10:40 AM Piper Jaffray Said ISIS Pharma (ISIS) To Get Royalty Payments from Alnylam/Roche deal

Apr 27, 2007 11:40 AM CE Unterberg Towbin initiates coverage on Rosetta Genomics (ROSG) at Buy

Dec 6, 2006 08:57 AM Needham Sets New $26 Price Target on Alnylam Pharmaceuticals (ALNY)

Nov 3, 2006 08:12 AM Bear Stearns downgrades Alnylam (ALNY) to Peer Perform

Oct 31, 2006 09:03 AM Needham Comments on Other Stocks in RNAi Following Merck's Deal to Buy Sirna Therapeutics

Sep 5, 2006 09:46 AM Bear Stearns Starts Alnylam Pharmaceuticals, Inc. (ALNY) at Outperform

Aug 24, 2006 09:14 AM Matrix USA Initiates Coverage on Alnylam Pharmaceuticals (ALNY) with a Strong Sell, Cantor Starts Coverage with Hold

Jun 20, 2006 07:47 AM Maxim Group Initiates Coverage on Alnylam Pharmaceuticals (ALNY) with a Buy

Jun 9, 2006 10:10 AM House and Senate Negotiators agreed on $2.3B Avian Flu Funding - Analyst

May 12, 2006 12:12 PM Caris & Co Initiates Coverage on Alnylam Pharmaceuticals (ALNY) with an Above Average

Back to ALNY Stock Lookup